Taltz
PHONETIC PRONUNCIATION: Taltz
Description
Taltz: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Taltz is a medication used to treat psoriasis and psoriatic arthritis. It is a type of biologic drug known as an interleukin-17A antagonist. Taltz works by blocking the action of interleukin-17A, which is a cytokine that is involved in the inflammation that causes psoriasis. This medication is administered by injection. Uses Taltz is primarily used to treat moderate to severe plaque psoriasis and active psoriatic arthritis in adults. It is also approved for use in juvenile idiopathic arthritis. Dosage The recommended dose of Taltz for psoriasis is 80 mg administered by injection every four weeks. For psoriatic arthritis, the recommended dose is 160 mg initially, followed by 80 mg every four weeks. The injection should be given into the thigh or abdominal area. Healthcare providers will help guide patients on how to administer the injection. Demographic Taltz is approved for use in adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is also approved for use in adults with active psoriatic arthritis and in pediatric patients with active juvenile idiopathic arthritis that are 6 years of age or older. Side Effects Like all medications, Taltz can cause side effects. The most common adverse reactions reported in clinical trials were injection site reactions, upper respiratory infections, nausea, and fungal infections. More serious side effects include allergic reactions, including anaphylaxis, and infections such as tuberculosis and bacterial, fungal, or viral infections. Patients with a history of tuberculosis should be screened for the latent form of the disease before starting Taltz. Interactions There are no known drug interactions with Taltz, although patients should discuss all their current medications and supplements with their healthcare provider before starting this medication. Generic Options Currently, there are no generic versions of Taltz available, as the drug is still under patent protection. However, there are other biologic drugs available for the treatment of psoriasis and psoriatic arthritis, including Humira, Enbrel, Stelara, and Cosentyx. In conclusion, Taltz is an effective medication used to treat psoriasis and psoriatic arthritis. It is important to discuss all treatment options with a healthcare provider in order to determine the best course of action based on each patient's unique medical history and needs. Patients taking Taltz should be aware of the potential side effects and the importance of regular monitoring by their healthcare provider to ensure safe and effective treatment.
Faq for Taltz
Taltz is used to treat moderate to severe plaque psoriasis in adults and psoriatic arthritis in adults.
Taltz works by inhibiting a specific protein in the body called interleukin-17A (IL-17A), which plays a role in the development of inflammatory diseases like plaque psoriasis and psoriatic arthritis.
Taltz is administered as a subcutaneous injection, which means it is injected just under the skin. It can be self-administered or administered by a healthcare professional.
Taltz is taken once every two weeks for the first three doses and then once every four weeks afterwards.
The common side effects of Taltz include injection site reactions, upper respiratory tract infections, nausea, and fungal or bacterial infections.
It is not recommended to use Taltz during pregnancy or while breastfeeding. Consult your doctor for more information.
Taltz can be used with certain other medications, but it is essential to inform your doctor about all the medications you are taking to avoid potential drug interactions.
Results with Taltz may vary for each individual, but some people may start to see improvements in their psoriasis symptoms within the first few weeks of treatment.
Taltz is covered by many insurance plans, including Medicare and Medicaid. However, coverage may vary, so it is advisable to check with your insurance provider for specific details.
Taltz is not recommended for use in children or adolescents under the age of 18. It is approved for use in adults only.
Taltz is used to treat moderate to severe plaque psoriasis in adults, psoriatic arthritis, and ankylosing spondylitis.
Taltz works by targeting specific proteins in the body that are involved in the inflammatory response, thereby reducing the inflammation associated with psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Common side effects of Taltz may include injection site reactions, upper respiratory tract infections, nausea, and fungal infections.
Taltz is typically taken as an injection once every two weeks for the first three months, and then once every four weeks thereafter.
It is important to discuss with your doctor about the potential risks and benefits of taking Taltz if you are pregnant or nursing, as the safety of the medication during pregnancy and breastfeeding has not been established.
Taltz is not approved for use in children under the age of 18 years. Safety and efficacy in pediatric patients have not been established.
It is important to inform your healthcare provider about any medical conditions, medications, or allergies you have before starting Taltz. Taltz may increase the risk of infection, so it is important to watch for signs of infection and seek medical attention if necessary.
The response time to Taltz can vary from person to person. Some individuals may start experiencing improvement in their symptoms within a few weeks, while for others, it may take longer.
There is no known interaction between alcohol and Taltz. However, it is best to consult with your doctor regarding alcohol consumption while on this medication.